HALO

AS OF

Sep 11 closing price

Price

$107.20

Change

+$0.20 (+0.19%)

Capitalization

12.16B

58 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

HALO

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Halozyme Therapeutics (HALO) Earnings Date & Reports

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

HALO is expected to report earnings to fall 1.75% to $2.24 per share on November 09

Halozyme Therapeutics HALO Stock Earnings Reports

Q3'26

Est.

$2.24

Q2'26

Beat

by $0.47

Q1'26

Beat

by $0.06

Q4'25

Missed

by $2.14

Q3'25

Beat

by $0.11

The last earnings report on August 06 showed earnings per share of $2.28, beating the estimate of $1.81. With 487.36K shares outstanding, the current market capitalization sits at 12.16B.

View a ticker or compare two or three

HALO

Daily Signal:

Gain/Loss:

Swing Trader for Mid Caps: Comprehensive Intrinsic Sentinel, 60 min, (FA)Swing Trader for Mid Caps: Comprehensive Intrinsic Sentinel, 60 min, (FA)

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for HALO

A.I. Advisor

published General Information

General Information

a developer of recombinant human enzymes for the infertility, ophthalmology and oncology markets

Industry Biotechnology

Profile

Details

Industry

Biotechnology

Address

12390 El Camino Real

Phone

+1 858 794-8889

Employees

423

Web

https://www.halozyme.com